The first blow is half the battle: Treatment optimisation for paediatric inflammatory bowel disease patients
The thesis was published by
Jongsma, Myrthe,
in April 2023,
Erasmus University Rotterdam.
Abstract:
This thesis show the first blow is half the battle in treating moderate-to-severe Crohn’s Disease patients. First-Line Infliximab treatment was superior to conventional treatment, with Exclusive Enteral Nutrition or prednisolon, in moderate-to-severe CD patients.